PARIS—French pharmaceutical giant Sanofi-Aventis has named Euro RSCG C&O as its corporate communications agency of record, responsible for internal editorial programs and publications. At the same time, the company selected Euro RSCG Life as global agency in charge of all communications for Lovenox/Clexane, the number one product for thrombosis treatment, and for Lantus and Apidra, market leading diabetes treatments.
Sanofi-Aventis will also work with Euro RSCG Life on communications programs for all new brands in these two therapeutic domains.
Euro RSCG parent Havas says the account wins are the fruit of real international collaboration with all Euro RSCG Worldwide’s teams in more than 40 countries. Sanofi-Aventis is Euro RSCG Worldwide’s first global pharmaceutical client.